Stanford University Cancer Center — Stanford, California

Stanford University Cancer Center is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford University Cancer Center has participated in 10 clinical trials.

Therapeutic areas: Persistent or Recurrent Cutaneous T-Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic Syndromes.

Sponsors: Eisai Inc., Celgene, Traws Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Cancer Center?

Stanford University Cancer Center has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Cancer Center conducted?

Stanford University Cancer Center has 10 clinical trials on record. Their work covers Persistent or Recurrent Cutaneous T-Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic Syndromes.

Is Stanford University Cancer Center accredited by Crixeo Clinical Trials?

Stanford University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.